News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Zinda Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Zinda Michael (EVP, Chief Scientific Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 6,404 shares
@ $12.03, valued at
$77k
Sold 2,869 shares
@ $12.02, valued at
$34.5k
|
|
| 06/07/2023 |
4
| Zinda Michael (EVP, Chief Scientific Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 1,200 shares
@ $12.04, valued at
$14.4k
|
|
| 02/01/2023 |
4
| Zinda Michael (EVP, Chief Scientific Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 24,550 shares
@ $0
Granted 97,100 options to buy
@ $12.42, valued at
$1.2M
|
|
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Exercised 115,000 options to buy
@ $15.63, valued at
$1.8M
|
|
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 16,100 shares
@ $27.2, valued at
$437.9k
Sold 3,900 shares
@ $27.87, valued at
$108.7k
|
|
| 08/20/2021 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 14,300 shares
@ $33.97, valued at
$485.8k
Sold 700 shares
@ $34.45, valued at
$24.1k
|
|
| 05/18/2021 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 732 shares
@ $31.6455, valued at
$23.2k
Sold 12,439 shares
@ $32.7239, valued at
$407.1k
Sold 1,829 shares
@ $33.0745, valued at
$60.5k
|
|
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 14,726 shares
@ $34.24, valued at
$504.2k
Sold 322 shares
@ $34.6, valued at
$11.1k
Sold 14,539 shares
@ $33.3, valued at
$484.1k
Sold 4,207 shares
@ $34.63, valued at
$145.7k
Sold 950 shares
@ $35.01, valued at
$33.3k
Exercised 48 options to buy
@ $2.062, valued at
$99 |
|
| 12/28/2020 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 1,612 shares
@ $34, valued at
$54.8k
Sold 39,700 shares
@ $33.36, valued at
$1.3M
Sold 12,556 shares
@ $33.48, valued at
$420.4k
Sold 3,679 shares
@ $34.26, valued at
$126k
Sold 432 shares
@ $33.14, valued at
$14.3k
Exercised 15,706 options to buy
@ $1.637, valued at
$25.7k
Exercised 25,606 options to buy
@ $2.062, valued at
$52.8k
Exercised 1,976 options to buy
@ $1.637, valued at
$3.2k
Exercised 4,771 options to buy
@ $2.062, valued at
$9.8k
Exercised 9,488 options to buy
@ $2.425, valued at
$23k
Exercised 432 options to buy
@ $2.062, valued at
$890.8 |
|
| 12/22/2020 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 40,000 shares
@ $33.08, valued at
$1.3M
Exercised 40,000 options to buy
@ $2.425, valued at
$97k
|
|
| 12/18/2020 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 8,022 shares
@ $35.17, valued at
$282.1k
Sold 934 shares
@ $36.01, valued at
$33.6k
Sold 8,121 shares
@ $34.59, valued at
$280.9k
Sold 200 shares
@ $35.1, valued at
$7k
Exercised 6,876 options to buy
@ $1.637, valued at
$11.3k
Exercised 2,080 options to buy
@ $1.637, valued at
$3.4k
Exercised 8,321 options to buy
@ $2.062, valued at
$17.2k
|
|
| 06/19/2020 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 41,240 options to buy
@ $20, valued at
$824.8k
|
|
|
|